Tempus, operated by Tempus AI, Inc., is an AI-enabled precision medicine platform built for biopharma R&D teams, clinical trial sponsors, diagnostic researchers, and oncologists. It connects clinical software, real-world multi-omics data, and laboratory infrastructure to address the fragmentation of healthcare data across oncology, cardiology, neurology, and psychiatry. The platform collects and structures multimodal data, including […]
drug-discovery
4 tools selected.
Recursion is a TechBio company that builds an end-to-end drug discovery platform called the Recursion OS. Its core interface, LOWE (LLM-Orchestrated Workflow Engine), lets scientists run drug discovery workflows using natural language prompts instead of manual lab coordination. LOWE connects proprietary biological data, computational tools, and automated wet labs into a single system. The platform […]
PatSnap is an AI-powered innovation intelligence platform that connects patent data with R&D, market, and commercial insights. It aggregates global patents, academic literature, clinical trials, regulatory filings, and company profiles. Organizations use it to analyze technology landscapes, evaluate competitors, and support innovation decisions. The platform targets a core problem in IP research: fragmented data spread […]
Numerion Labs is an AI drug hunting platform for therapeutic discovery and molecular engineering. The company was previously known as Atomwise, founded in 2015 through Y Combinator. It is based in San Francisco and led by CEO Steve Worland. The platform centers on three named systems. COSMOS is a universal chemistry foundation model that predicts […]